• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可乐定在阿片类药物脱毒中的应用。

The use of clonidine in detoxification from opiates.

作者信息

Kleber H D, Gold M S, Riordan C E

出版信息

Bull Narc. 1980;32(2):1-10.

PMID:6907020
Abstract

Use of clonidine hydrochloride in detoxification from opiates has demonstrated that this substance can rapidly suppress the signs and symptoms associated with opiate withdrawal. Clonidine hydrochloride, an alpha-adrenergic agonist, is a non-opiate substance. Studies to date indicate that clonidine is useful for withdrawal from methadone maintenance, where it can help in detoxifying the patient in less than 14 days (instead of the usual three to six months) with a high rate of success in achieving zero dosage. The results of a clinical investigation of clonidine are presented and discussed in this paper. It has been shown to suppress signs and symptoms of opiate withdrawal in patients taking up to 75 mg of methadone daily. Shorter-acting narcotics may be withdrawn in less than a week. To prevent relapse, post-detoxification counselling and the use of the narcotic antagonist, naltrexone, are recommended.

摘要

盐酸可乐定在阿片类药物脱毒治疗中的应用表明,该物质能迅速抑制与阿片类药物戒断相关的体征和症状。盐酸可乐定是一种α-肾上腺素能激动剂,属于非阿片类物质。迄今为止的研究表明,可乐定对美沙酮维持治疗的脱毒有效,它能在不到14天的时间内帮助患者脱毒(而非通常的三至六个月),且在实现零剂量方面成功率很高。本文介绍并讨论了可乐定的一项临床研究结果。已证明它能抑制每日服用多达75毫克美沙酮患者的阿片类药物戒断体征和症状。作用时间较短的麻醉药品可在不到一周的时间内停用。为防止复发,建议进行脱毒后咨询并使用麻醉拮抗剂纳曲酮。

相似文献

1
The use of clonidine in detoxification from opiates.可乐定在阿片类药物脱毒中的应用。
Bull Narc. 1980;32(2):1-10.
2
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.可乐定治疗阿片类戒断综合征。一种理论的临床试验综述。
Acta Psychiatr Scand Suppl. 1986;327:91-113.
3
Clonidine in opiate withdrawal: review and appraisal of clinical findings.可乐定用于阿片类药物戒断:临床研究结果的回顾与评估
Pharmacotherapy. 1981 Sep-Oct;1(2):140-6. doi: 10.1002/j.1875-9114.1981.tb03561.x.
4
Psychiatric indications for clonidine: the neuropharmacologic and clinical basis.可乐定的精神科适应证:神经药理学及临床基础
J Clin Psychopharmacol. 1986 Apr;6(2):81-7.
5
Clonidine and the treatment of the opiate withdrawal syndrome.可乐定与阿片类戒断综合征的治疗
Drug Alcohol Depend. 1988 Jul;21(3):253-9. doi: 10.1016/0376-8716(88)90078-6.
6
[Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].可乐定-纳曲酮:一种用于阿片类成瘾者戒毒的新技术
Med Clin (Barc). 1990 Nov 10;95(16):627-9.
7
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.阿片类药物成瘾与蓝斑核。可乐定、纳曲酮、美沙酮和丁丙诺啡的临床应用。
Psychiatr Clin North Am. 1993 Mar;16(1):61-73.
8
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.阿片戒断综合征治疗期间睡眠的严重干扰:美沙酮与洛非西定脱毒治疗的差异
Addict Biol. 2003 Mar;8(1):49-57. doi: 10.1080/1355621031000069882.
9
Outpatient opiate detoxification with clonidine.可乐定用于门诊阿片类药物脱毒治疗。
J Clin Psychiatry. 1982 Jun;43(6 Pt 2):39-41.
10
Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.阿片类药物脱毒的替代策略:对所谓超快速脱毒的评估。
Pharmacopsychiatry. 1998 Nov;31(6):205-9. doi: 10.1055/s-2007-979329.

引用本文的文献

1
Fentanyl-Antibody Interaction as a Novel Strategy against Opiates and Opioids Abuse.芬太尼-抗体相互作用作为一种对抗阿片类药物滥用的新策略。
J Med Chem. 2025 Apr 24;68(8):7866-7888. doi: 10.1021/acs.jmedchem.4c02860. Epub 2025 Apr 3.
2
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.可乐定作为α-2A受体激动剂治疗成瘾行为的历史视角:聚焦于阿片类药物依赖
INNOSC Theranostics Pharmacol Sci. 2024;7(3). doi: 10.36922/itps.1918. Epub 2024 Jul 29.
3
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.
强化转化研究:需要利用成瘾药物的复杂临床前模型来加速物质使用治疗方案。
Pharmacol Biochem Behav. 2024 Oct;243:173836. doi: 10.1016/j.pbb.2024.173836. Epub 2024 Jul 26.
4
Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine.盐酸丁丙诺啡对芬太尼需求、体重和大鼠急性戒断的影响:与可乐定的比较。
Neuropharmacology. 2024 Mar 1;245:109816. doi: 10.1016/j.neuropharm.2023.109816. Epub 2023 Dec 20.
5
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.在医学监督下的阿片类药物戒断期间使用美沙酮或丁丙诺啡与长效注射用纳曲酮诱导失败之间的关联。
J Subst Abuse Treat. 2021 May;124:108292. doi: 10.1016/j.jsat.2021.108292. Epub 2021 Jan 16.
6
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?与阿片类药物使用障碍(OUD)相关的大脑奖励回路的神经相关性:智人是否会出现或具有奖励缺陷综合征?
J Neurol Sci. 2020 Nov 15;418:117137. doi: 10.1016/j.jns.2020.117137. Epub 2020 Sep 15.
7
Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.精神活性药物与基于办公室的丁丙诺啡阿片类药物治疗(OBOT)的脱失
Drug Alcohol Depend. 2017 Jan 1;170:9-16. doi: 10.1016/j.drugalcdep.2016.10.039. Epub 2016 Nov 5.
8
Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.恒河猴中吗啡与Δ9-四氢大麻酚联合治疗:抗伤害感受耐受性与戒断反应
J Pharmacol Exp Ther. 2016 May;357(2):357-66. doi: 10.1124/jpet.115.231381. Epub 2016 Mar 2.
9
Substance Use Disorder Counselors' Reports of Tobacco Cessation Services Availability, Implementation, and Tobacco-related Knowledge.物质使用障碍咨询师关于戒烟服务的可获得性、实施情况及烟草相关知识的报告。
J Adolesc Health. 2015 Sep;57(3):327-33. doi: 10.1016/j.jadohealth.2015.06.001.
10
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.吗啡耐受的恒河猴对大麻素的交叉耐受性。
Psychopharmacology (Berl). 2015 Oct;232(19):3637-47. doi: 10.1007/s00213-015-4023-x. Epub 2015 Jul 23.